Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2013 2
2015 1
2017 2
2018 2
2019 3
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Results by year
Filters applied: . Clear all
Page 1
A Platform of Synthetic Lethal Gene Interaction Networks Reveals that the GNAQ Uveal Melanoma Oncogene Controls the Hippo Pathway through FAK.
Feng X, Arang N, Rigiracciolo DC, Lee JS, Yeerna H, Wang Z, Lubrano S, Kishore A, Pachter JA, König GM, Maggiolini M, Kostenis E, Schlaepfer DD, Tamayo P, Chen Q, Ruppin E, Gutkind JS. Feng X, et al. Among authors: lubrano s. Cancer Cell. 2019 Mar 18;35(3):457-472.e5. doi: 10.1016/j.ccell.2019.01.009. Epub 2019 Feb 14. Cancer Cell. 2019. PMID: 30773340 Free PMC article.
[Placenta accreta: screening, management and complications].
Héquet D, Ricbourg A, Sebbag D, Rossignol M, Lubrano S, Barranger E. Héquet D, et al. Among authors: lubrano s. Gynecol Obstet Fertil. 2013 Jan;41(1):31-7. doi: 10.1016/j.gyobfe.2012.11.001. Epub 2013 Jan 3. Gynecol Obstet Fertil. 2013. PMID: 23291052 Review. French.
[Autism spectrum disorders, a pilot parent-child unit].
Bonnard-Couton V, Lubrano S, Tosello AL, Serret S, Askenazy-Gittard F. Bonnard-Couton V, et al. Among authors: lubrano s. Soins Pediatr Pueric. 2018 Nov-Dec;39(305):37-41. doi: 10.1016/j.spp.2018.09.010. Soins Pediatr Pueric. 2018. PMID: 30449399 French.
Identification of BRAF 3'UTR Isoforms in Melanoma.
Marranci A, Tuccoli A, Vitiello M, Mercoledi E, Sarti S, Lubrano S, Evangelista M, Fogli A, Valdes C, Russo F, Monte MD, Caligo MA, Pellegrini M, Capobianco E, Tsinoremas N, Poliseno L. Marranci A, et al. Among authors: lubrano s. J Invest Dermatol. 2015 Jun;135(6):1694-1697. doi: 10.1038/jid.2015.47. Epub 2015 Feb 16. J Invest Dermatol. 2015. PMID: 25685929 Free article. No abstract available.
Early modifications of circulating microRNAs levels in metastatic colorectal cancer patients treated with regorafenib.
Schirripa M, Borelli B, D'Aurizio R, Lubrano S, Cremolini C, Zucchelli G, Antoniotti C, Marmorino F, Prete AA, Murgioni S, Bergamo F, Zagonel V, Tuccoli A, Marranci A, Rizzo M, Tedeschi L, Magnoni L, Falcone A, Loupakis F, Poliseno L. Schirripa M, et al. Among authors: lubrano s. Pharmacogenomics J. 2019 Oct;19(5):455-464. doi: 10.1038/s41397-019-0075-3. Epub 2019 Jan 28. Pharmacogenomics J. 2019. PMID: 30686821
The landscape of BRAF transcript and protein variants in human cancer.
Marranci A, Jiang Z, Vitiello M, Guzzolino E, Comelli L, Sarti S, Lubrano S, Franchin C, Echevarría-Vargas I, Tuccoli A, Mercatanti A, Evangelista M, Sportoletti P, Cozza G, Luzi E, Capobianco E, Villanueva J, Arrigoni G, Signore G, Rocchiccioli S, Pitto L, Tsinoremas N, Poliseno L. Marranci A, et al. Among authors: lubrano s. Mol Cancer. 2017 Apr 28;16(1):85. doi: 10.1186/s12943-017-0645-4. Mol Cancer. 2017. PMID: 28454577 Free PMC article.
Development of a yeast-based system to identify new hBRAFV600E functional interactors.
Lubrano S, Comelli L, Piccirilli C, Marranci A, Dapporto F, Tantillo E, Gemignani F, Gutkind JS, Salvetti A, Chiorino G, Cozza G, Chiariello M, Galli A, Poliseno L, Cervelli T. Lubrano S, et al. Oncogene. 2019 Feb;38(8):1355-1366. doi: 10.1038/s41388-018-0496-5. Epub 2018 Sep 20. Oncogene. 2019. PMID: 30237439
Context-dependent miR-204 and miR-211 affect the biological properties of amelanotic and melanotic melanoma cells.
Vitiello M, Tuccoli A, D'Aurizio R, Sarti S, Giannecchini L, Lubrano S, Marranci A, Evangelista M, Peppicelli S, Ippolito C, Barravecchia I, Guzzolino E, Montagnani V, Gowen M, Mercoledi E, Mercatanti A, Comelli L, Gurrieri S, Wu LW, Ope O, Flaherty K, Boland GM, Hammond MR, Kwong L, Chiariello M, Stecca B, Zhang G, Salvetti A, Angeloni D, Pitto L, Calorini L, Chiorino G, Pellegrini M, Herlyn M, Osman I, Poliseno L. Vitiello M, et al. Among authors: lubrano s. Oncotarget. 2017 Apr 11;8(15):25395-25417. doi: 10.18632/oncotarget.15915. Oncotarget. 2017. PMID: 28445987 Free PMC article.
Synthetic Lethal Screens Reveal Cotargeting FAK and MEK as a Multimodal Precision Therapy for GNAQ-Driven Uveal Melanoma.
Paradis JS, Acosta M, Saddawi-Konefka R, Kishore A, Gomes F, Arang N, Tiago M, Coma S, Lubrano S, Wu X, Ford K, Day CP, Merlino G, Mali P, Pachter JA, Sato T, Aplin AE, Gutkind JS. Paradis JS, et al. Among authors: lubrano s. Clin Cancer Res. 2021 Jun 1;27(11):3190-3200. doi: 10.1158/1078-0432.CCR-20-3363. Epub 2021 Feb 10. Clin Cancer Res. 2021. PMID: 33568347
11 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page